Company Profile
Sanara MedTech Stock Price, News & Analysis
- Ticker:
- SMTI
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
34.09 USD (+0.06%)
Close
Last updated: August 6, 2026
195M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, SMTI was little changed and closed at $34.09. No new same-company headline was identified in the current news window.
Company overview
Surgical Wound and Tissue Repair
Sanara MedTech develops and commercializes products intended to improve surgical healing and reduce complications and healthcare costs.
Soft-Tissue Repair Portfolio
The company’s products address wound cleansing, infection management, extracellular matrix support, and tissue repair across surgical specialties.
Procedure-Based Commercial Model
Sanara sells through hospital and surgeon relationships, with revenue driven by procedure volumes, product adoption, and expansion of its direct commercial organization.
Technology Acquisition Strategy
The company supplements internal development with licensed and acquired technologies that can be distributed through its existing surgical channel.
Future catalysts
Sanara MedTech’s catalysts are wound-care and surgical-product sales, along with continued execution in specialty care. It is a steady operating story, so the market will focus on adoption and margin discipline.
Recent news
- 01
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
Source: Sanara MedTech
- 02
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
Source: Sanara MedTech
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Sanara MedTech (SMTI)?
Sanara MedTech (SMTI) most recently closed at 34.09 USD, a +0.06% move versus the previous session.
What is the market cap of Sanara MedTech (SMTI)?
Sanara MedTech currently has a market capitalization of 195M USD on BioPharmSignal.
What does Sanara MedTech do?
Surgical Wound and Tissue Repair Sanara MedTech develops and commercializes products intended to improve surgical healing and reduce complications and healthcare costs. Soft-Tissue Repair Portfolio The company’s products address wound cleansing, infection management, extracellular matrix support, and tissue repair across surgical...
On which exchange is SMTI stock listed?
Sanara MedTech (SMTI) is associated with NASDAQ, United States, Biopharma.
What is Surgical?
Sanara MedTech’s catalysts are wound-care and surgical-product sales, along with continued execution in specialty care.
Which conditions is Sanara MedTech targeting with Surgical?
Sanara MedTech’s catalysts are wound-care and surgical-product sales, along with continued execution in specialty care.
How does Sanara MedTech describe recent progress with Surgical?
Sanara MedTech’s catalysts are wound-care and surgical-product sales, along with continued execution in specialty care.
What is Wound?
Surgical Wound and Tissue Repair Sanara MedTech develops and commercializes products intended to improve surgical healing and reduce complications and healthcare costs.